Dimensional Fund Advisors’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Dimensional Fund Advisors’s Portfolio DRNA Stock Details DRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-17,952	Closed	-$283K	–	3451
2019 Q2	$283K	Buy	+17,952	New	+$244K	﹤0.01%	3272
2018 Q3	–	Sell	-18,244	Closed	-$223K	–	3441
2018 Q2	$223K	Hold	18,244	–	–	﹤0.01%	3235
2018 Q1	$174K	Hold	18,244	–	–	﹤0.01%	3244
2017 Q4	$165K	Sell	18,244 -9,098	-33%	-$66.9K	﹤0.01%	3245
2017 Q3	$157K	Sell	27,342 -4,682	-15%	-$17K	﹤0.01%	3244
2017 Q2	$102K	Sell	32,024 -4,954	-13%	-$15.6K	﹤0.01%	3252
2017 Q1	$126K	Hold	36,978	–	–	﹤0.01%	3235
2016 Q4	$106K	Buy	36,978 +2,705	+8%	+$9.62K	﹤0.01%	3236
2016 Q3	$202K	Hold	34,273	–	–	﹤0.01%	3181
2016 Q2	$103K	Buy	34,273 +10,616	+45%	+$43.6K	﹤0.01%	3234
2016 Q1	$127K	Buy	23,657 +11,047	+88%	+$69.7K	﹤0.01%	3220
2015 Q4	$150K	Buy	+12,610	New	+$144K	﹤0.01%	3238

Other funds holding DRNA

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Dimensional Fund Advisors's DRNA Position: Q3 2019 in Review

Dimensional Fund Advisors sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q3 2019, closing a stake of 17,952 shares — an estimated $283K sold.

Dimensional Fund Advisors first reported a position in DRNA in Q4 2015 and held it in 12 quarters. The position peaked at $283K in Q2 2019. 112 funds tracked by Wall St. Rank hold DRNA as of Q3 2019.

Dimensional Fund Advisors reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q3 2019 after selling out during the quarter.
Dimensional Fund Advisors sold 17,952 Dicerna Pharmaceuticals, Inc. shares in Q3 2019, an estimated $283K.
Dimensional Fund Advisors first reported a position in Dicerna Pharmaceuticals, Inc. in Q4 2015 and held it in 12 quarters.
Dimensional Fund Advisors's Dicerna Pharmaceuticals, Inc. position peaked at $283K in Q2 2019.
112 funds tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q3 2019.

Based on Dimensional Fund Advisors's 13F filing for Q3 2019, filed 12 Nov 2019.